Rebalix
Logo InvescoInvesco · sheet of 10 September 2026
ETF sheet · official issuer and register data

Invesco STOXX Europe 600 Optimised Retail UCITS ETF Acc

XRPS · IE00B5MTZM66 · class Acc · EUR · domicile Ireland
Equity · Europe · ConsumerSFDR art. 6
Index tracked: STOXX® Europe 600 Optimised Retail Total Return (Net) Index
TER
0.20%+ trans. 0.00%
Fund size
1 m EUR
Tracking difference
−0.20%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 7 Jul 2009 · costs from the KID as of 14 Aug 2026 · 73 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve the net total return performance of the STOXX Europe 600 Optimised Retail Index (the "Index"), less fees, expenses and transaction costs. Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with…

Performance since series start (in euro) — base 100

7 Jul 200913 Aug 2026 · dividends reinvested where declared by the issuer
201020132016201920222025303100302
High 303 (11 Aug 2026) · low 100 (7 Jul 2009) · last 302. Past performance is not indicative of future results.

Returns in euro

1 year+16.8%
3 years+35.0%
5 years+6.3%
10 years+71.0%
Since series start+201.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)19.14%18.48%22.05%
Max drawdown−14.77%−19.40%−49.72%
Sharpe0.450.340.03
Sortino0.640.490.04
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · XRPS · IE00B5MTZM661
RebalixXRPS · IE00B5MTZM66 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+8.33%+8.53%−0.20%
2024+8.72%+8.91%−0.20%
2023+35.97%+36.18%−0.21%
2022−33.21%−33.08%−0.12%
2021+12.46%+12.79%−0.34%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 73 securities · top-10 weight = 29.2%
Top holdingsWeight
ZURICH INSURANCE GROUP AG4.3%
D/S NORDEN4.2%
DSV A/S3.3%
JULIUS BAER GROUP LTD3.2%
HUFVUDSTADEN AB-A SHS2.8%
UBS GROUP AG-REG2.5%
INDUSTRIVARDEN AB-A SHS2.4%
ROCHE HOLDING AG2.3%
BOLIDEN AB2.1%
NOVARTIS AG-REG2.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
XRPS · Xetra (Deutsche Börse)
+ 11 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00B5MTZM66
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · XRPS · IE00B5MTZM662